脂质代谢相关基因变异在早发冠心病中作用的研究进展

www.yongyao.net　　2009-10-10 10:46:06　　来源：　　责任编辑：

分享到：

参考文献(References):
[1] WANG Xiao-Ling, GU Dong-Feng. Progress in researches on coronary heart disease genetics. Chin J Genet, 2000,17:452-454.
王晓玲, 顾东风. 冠心病遗传因素的研究进展. 中华医学遗传杂志, 2000,17: 452-454.
[2] Marteau JB. Genetic variants predisposing to cardiovascular disease. Curr Opin Lipidol, 2006, 7(2): 139-151.
[3] Chaer RA, Billeh R, Massad MG. Genetics and gene manipulation therapy of premature coronary artery disease.Cardiology, 2004, 101(1-3): 122-130.
[4] Zdravkovic S, Wienke A, Pedersen NL, Marenberg ME,Yashin AI, De Faire U. Heritability of death from coronary heart disease: a 36-year follow-up of 20,966 Swedish twins. J Intern Med, 2002, 252(3): 247-254.
[5] Punzalan FE, Sy RG, Santos RS, Cutiongco EM,Gosiengfiao S, Fadriguilan E, George P, Laurie A. Low
density lipoprotein-receptor (LDL-R) gene mutations among Filipinos with familial hypercholesterolemia. J AtherosclerThromb, 2005,12(5): 276-283.
[6] Kastelein JJ, van Leuven SI, Burgess L, Evans GW,Kuivenhoven JA, Barter PJ, Revkin JH, Grobbee DE,Riley WA, Shear CL, Duggan WT, Bots ML; RADIANCE1 Investigators. Effect of torcetrapib on carotid atherosclerosisin familial hypercholesterolemia. N Engl J Med,2007, 356(16): 1620-1630.
[7] Deepak B. Diagnosis and screening for familial hypercholesterolaemia:finding the patients, finding the genes.Ann Clin Biochem, 2006,43(pt6): 441-456.
[8] Yuan G, Wang J, Hegele RA. Heterozygous familial hypercholesterolemia:an underrecognized cause of early cardiovascular disease. CMAJ, 2006, 174(8): 1124-1129.
[9] Wiegman A, de Groot E, Hutten BA, Rodenburg J, Gort J,Bakker HD, Sijbrands EJ, Kastelein JJ. Arterial intimamedia thickness in children heterozygous for familial hypercholesterolaemia.
Lancet, 2004, 363 (9406): 369-370.
[10] Soutar AK, Naoumova RP. Mechanisms of Disease: genetic causes of familial hypercholesterolemia. Nat ClinPract Cardiovasc Med, 2007, 4(4): 214-225.
[11] Plewa R, ?uczak M, Burchardt P, Bolewski A, WierzchowieckiJ, Siminiak T. Monogenic hypercholesterolaemias an evaluation of apolipoprotein B100 and LDL receptor gene polymorphisms. Kardiol Pol, 2006,64(2): 127-133.
[12] Chiodini BD, Barlera S, Franzosi MG, Beceiro VL,Introna M, Tognoni G. APOB gene polymorphisms and coronary artery disease: a meta-analysis. Atherosclerosis,2003, 167(2): 355-366.
[13] Puri RD, Tewari S, Sinha N, Ramesh V, Khan F, Singh VP,Agrawal S. Polymorphisms in the apolipoprotein B-100 gene: association with plasma lipid concentration and coronary artery disease. Indian Heart J, 2003, 55(1):60-64.
[14] Song Y, Stampfer MJ, Liu S. Meta-analysis: Apolipoprotein E genotypes and risk for coronary heart disease.Ann Intern Med, 2004, 141(2): 137-147.
[15] Viiri LE, Raitakari OT, Huhtala H, K?h?nen M, Rontu R,Juonala M, Hutri-K?h?nen N, Marniemi J, Viikari JS,Karhunen PJ, Lehtim/ki T. Relations of APOE promoter polymorphisms to LDL cholesterol and markers of subclinical atherosclerosis in young adults. J Lipid Res, 2006,47(6): 1298-1306.
[16] Sviridov D, Nestel PJ. Genetic factors affecting HDL levels,structure, metabolism and function. Curr Opin Lipidol,2007, 18(2): 157-163.
[17] Uehara Y, Tsuboi Y, Zhang B, Miura SI, Baba Y, Higuchi MA, Yamada T, Rye KA, Saku K. POPC/apoA-I disease as a potent lipoprotein modulator in Tangier disease.Atherosclerosis, 2008, 197(1): 283-289.
[18] Soro-Paavonen A, Naukkarinen J, Lee-Rueckert M, Watanabe H, Rantala E, Soderlund S, Hiukka A, Kovanen PT,Jauhiainen M, Peltonen L, Taskinen MR. Common ABCA1 variants, HDL levels, and cellular cholesterol efflux in subjects with familial low HDL. J Lipid Res, 2007,48(6): 1409-1416.
[19] Nebel A, Croucher PJ, El Mokhtari NE, Flachsbart F,Schreiber S. Common coding polymorphisms in the ABCA1 gene and risk of early-onset coronary heart disease in northern Germany. Atherosclerosis, 2007, 193(2):458-460.
[20] LI Ya, ZHANG Si-Zhong, MA Yong-Xin, HE Yong,DONG Jing-Tao, SUN Yan, HE Guo-Ping, ZHANG Wei.
Relationship between the R219K polymorphism of ATP-binding cassette transporter 1 gene and coronary
heart disease. Hereditas(Beijing), 2005, 27(4): 549-552.
李亚, 张思仲, 马用信, 贺勇, 董景涛, 孙岩, 何国平,张炜. ABCA1 基因多态性与冠心病相关性研究. 遗传, 2005, 27(4): 549-552.
[21] Kyriakou T, Pontefract DE, Viturro E, Hodgkinson CP,Laxton RC, Bogari N, Cooper G, Davies M, Giblett J, DayIN, Simpson IA, Albrecht C, Ye S. Functional polymorphism in ABCA1 influences age of symptom onset in coronary artery disease patients. Hum Mol Genet, 2007,16(12): 1412-1422.
[22] Nieminen T, Khnen M, Islam S, Raitakari OT,Hutri-Khnen N, Marniemi J, Juonala M, Rontu R, ViikariJ, Lehtimki T. Apolipoprotein A-Ⅰ/C-Ⅲ/A-Ⅳ SstⅠand apolipoprotein B XbaⅠ polymorphisms do not affect early functional and structural changes in atherosclerosis.The Cardiovascular Risk in Young Finns study. Circ J,2007, 71(5): 741-745.
[23] Eberini I, Gianazza E, Breghi L, Klugmann S, Calabresi L,Gomaraschi M, Mombelli G, Brusoni B, Wait R, Sirtori CR. Apolipoprotein A-I breakdown is induced by thrombolysis in coronary patients. Ann Med, 2007, 39(4):306-311.
[24] DU Ji-Kun, HUANG Qing-Yang. Research progress of Lipoprotein lipase gene. Hereditas(Beijing), 2007, 29(1):8-?16.
杜纪坤, 黄青阳. 脂蛋白脂酶基因的研究进展. 遗传,2007, 29(1): 8-16.
[25] Hu Y, Liu W, Huang R, Zhang X. A systematic review and meta-analysis of the relationship between lipoprotein lipase Asn291Ser variant and diseases. J Lipid Res, 2006,47(9): 1908-1914.
[26] Almeida KA, Strunz CM, Maranh?o RC, Mansur AP. The S447X polymorphism of lipoprotein lipase: effect on the incidence of premature coronary disease and on plasma lipids. Arq Bras Cardiol, 2007, 88(3): 297-303.
[27] LIU He-Kun, CHEN Su-Yun, ZHANG Si-Zhong, XIAO Cui-Ying, REN Yan, TIAN Hao-Ming, LI Xue-Fei. Adiponectin gene variation ?4522C/T is associated with type diabetic obesity and insulin resistance in Chinese. JGenet Genomics, 2007, 34(10): 877-884.
刘合刘, 陈素云, 张思仲, 肖翠英, 任艳, 田浩明, 李雪飞. 脂联素基因单核苷酸多态性与Ⅱ型糖尿病合并肥胖及胰岛素抵抗相关联. 遗传学报, 2007, 34(10):877-884.
[28] Koz C, Uzun M, Yokusoglu M, Baysan O, Erinc K, Sag C,Hasimi A, Isik E. Evaluation of plasma adiponectin levels in young men with coronary artery disease. Acta Cardiol,2007, 62(3): 239-243.
[29] Filippi E, Sentinelli F, Romeo S, Arca M, Berni A, TibertiC, Verrienti A, Fanelli M, Fallarino M, Sorropago G,Baroni MG. The adiponectin gene SNP+276G>T associates with early-onset coronary artery disease and with lower levels of adiponectin in younger coronary artery disease patients (age ≤50 years). J Mol Med, 2005, 83(9):711-719.
[30] Ohashi K, Ouchi N, Kihara S, Funahashi T, Nakamura T,Sumitsuji S, Kawamoto T, Matsumoto S, Nagaretani H,Kumada M, Okamoto Y, Nishizawa H, Kishida K, MaedaN, Hiraoka H, Iwashima Y, Ishikawa K, Ohishi M, KatsuyaT, Rakugi H, Ogihara T, Matsuzawa Y. AdiponectinI164T mutation is associated with the metabolic syndrome and coronary artery disease. J Am Coll Cardiol, 2004,43(7): 11951200.
[31] Overton CD, Yancey PG, Major AS, Linton MF, Fazio S.Deletion of macrophage LDL receptor-related protein increases atherogenesis in the mouse. Circ Res, 2007, 100(5):670-677.
[32] Shen GQ, Li L, Girelli D, Seidelmann SB, Rao S, Fan C,Park JE, Xi Q, Li J, Hu Y, Olivieri O, Marchant K, BarnardJ, Corrocher R, Elston R, Cassano J, Henderson S,Hazen SL, Plow EF, Topol EJ, Wang QK. An LRP8 variant is associated with familial and premature coronary artery disease and myocardial infarction. Am J Hum Genet,2007, 81(4): 780-791.